Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Impact of Endogenous Insulin Secretion on Clinical Outcomes in Type 1 Diabetes and the Optimal Approach to C-peptide Measurement for Outcome Prediction

NCT07828626 is registered in ClinicalTrials.gov with Royal Devon and Exeter NHS Foundation Trust as lead sponsor.

NCT NCT07828626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07828626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Impact of Endogenous Insulin Secretion on Clinical Outcomes in Type 1 Diabetes and the Optimal Approach to C-peptide Measurement for Outcome Prediction
Lead sponsor
Royal Devon and Exeter NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2025
Completion date
June 30, 2027
Enrollment
700 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes (dm), diabetes (insulin-requiring, type 1 or type 2), type 1 diabetes (t1d)